A new review in Virology Journal examines how siRNA and CRISPR/Cas gene-silencing technologies could target the HPV16 ...

CRISPR-Cas13 has rapidly become one of the most versatile tools in plant biotechnology, offering researchers the ability to ...

What you will learn in this article On September 23, 2026, Anthropic announced that Claude agents explored over 200,000 reverse transcriptases (RTs), extracted approximately 3,500 new candidate ...

IntroductionCRISPR-Cas has fundamentally transformed the landscape of genetic manipulation in life sciences. This technology, which recognizes, cuts, and edits specific DNA sequences, is utilized in a ...

Claude AI biology discovery: Anthropic's Claude Mythos 5 agents autonomously searched 1.9 billion protein clusters and identified ART, a previously uncharacterized enzyme system in bacteriophage DNA ...

Anthropic's Claude found ART, an enzyme system with CRISPR-like repeat sequences. We examine the paper's experimental results ...

Beam Therapeutics is reaffirmed as a long-term buy, with significant upside expected around 2028–2029 as BEAM-302 advances.

A groundbreaking Phase 1 clinical trial conducted by Cleveland Clinic has unveiled promising results regarding a novel CRISPR ...

Anthropic’s claim its AI agents discovered an unusual pattern in viral DNA similar to what’s seen in the gene-editing tool ...

Gene-editing techniques could soon allow researchers to replace entire genes and engineer complex cellular circuits — if the ...

CRISPR may be a powerful technology for gene editing, but the system existed in bacteria long before scientists began using it. For billions of years, CRISPR has acted as a natural immune system in ...